Drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, a biodegradable synthetic polymer in the form of particles for structured drug release of active pharmaceutical ingredients; drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, implants composed of biodegradable materials in the nature of living tissue

Drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, a biodegradable synthetic polymer in the form of particles for structured drug release of active pharmaceutical ingredients; drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, implants composed of biodegradable materials in the nature of living tissue

Drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, a biodegradable synthetic polymer in the form of particles for structured drug release of active pharmaceutical ingredients; drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, implants composed of biodegradable materials in the nature of living tissue

Drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, a biodegradable synthetic polymer in the form of particles for structured drug release of active pharmaceutical ingredients; drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, implants composed of biodegradable materials in the nature of living tissue

Drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, a biodegradable synthetic polymer in the form of particles for structured drug release of active pharmaceutical ingredients; drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, implants composed of biodegradable materials in the nature of living tissue

Drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, a biodegradable synthetic polymer in the form of particles for structured drug release of active pharmaceutical ingredients; drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, implants composed of biodegradable materials in the nature of living tissue

Drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, a biodegradable synthetic polymer in the form of particles for structured drug release of active pharmaceutical ingredients; drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, implants composed of biodegradable materials in the nature of living tissue

Drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, a biodegradable synthetic polymer in the form of particles for structured drug release of active pharmaceutical ingredients; drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, implants composed of biodegradable materials in the nature of living tissue

Drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, a biodegradable synthetic polymer in the form of particles for structured drug release of active pharmaceutical ingredients; drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, implants composed of biodegradable materials in the nature of living tissue

Drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, a biodegradable synthetic polymer in the form of particles for structured drug release of active pharmaceutical ingredients; drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, implants composed of biodegradable materials in the nature of living tissue

drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, a biodegradable synthetic polymer in the form of particles for structured drug release of active pharmaceutical ingredients; drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, implants composed of biodegradable materials in the nature of living tissue

drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, a biodegradable synthetic polymer in the form of particles for structured drug release of active pharmaceutical ingredients; drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, implants composed of biodegradable materials in the nature of living tissue

Drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, a biodegradable synthetic polymer in the form of particles for structured drug release of active pharmaceutical ingredients; drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, implants composed of biodegradable materials in the nature of living tissue

Drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, a biodegradable synthetic polymer in the form of particles for structured drug release of active pharmaceutical ingredients; drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, implants composed of biodegradable materials in the nature of living tissue

drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, a biodegradable synthetic polymer in the form of particles for structured drug release of active pharmaceutical ingredients; drug, agent and cell delivery system comprised of a range of biomaterial formulations for neurological use, namely, implants composed of biodegradable materials in the nature of living tissue

synthetic injectable biomaterial that provides structural support to tissue, tissue re-engineering, as well as support for cell regeneration in the brain and spinal cord, all for medical purposes